scholarly journals Valvular heart diseases. (3). Evaluation of late results of aortic valve replacement with 19mm St. Jude Medical prosthesis using M-mode echocardiogram and continuous Doppler echocardiogram.

1990 ◽  
Vol 19 (4) ◽  
pp. 705-708
Author(s):  
T. Watanabe
2021 ◽  
pp. 22-26
Author(s):  
Inkar Sagatov ◽  
◽  
Askhat Kudaibergen ◽  
Bakhytzhan Momynov

Valve defects or congenital/acquired heart defects are damage to the valve and/or subvalvular structures, which leads to impaired hemodynamics and the development of heart failure. Asymptomatic valvular heart disease is present in 2.5% of the population; with age, this figure rises to 13%. In the absence of permanent treatment, lesions of the heart valves significantly reduce the quality and duration of life. The European Society of Cardiology (ESC) and the American Heart Association (AHA) regularly review the effectiveness of new surgical treatments and reflect their findings in international guidelines. Today, minimally invasive surgery is the most effective and safe way to treat patients with valvular heart disease. The article presents two new methods for the treatment of valvular heart disease. Transapical mitral valve repair on a beating heart with neochord implantation (TOP-MINI) is a new MVP option that has been approved for patients with severe mitral regurgitation due to prolapse of the leaflet (s) or chord (grades 2-4). The new procedure with the NeoChord DS1000 device results in a significant reduction in mitral regurgitation and in reverse remodeling of the left ventricle and left atrium after 6 months of follow-up. Also reviewed is Minimally Invasive Aortic Valve Replacement (MAVR), which has been shown to be beneficial in improving patient satisfaction by minimizing pain and earlier recovery. Sutureless valves are preferred over traditional aortic valve replacement (AVR) due to the reduced operation time and the need for blood transfusion. The Perceval valve (Sorin, Sallugia, Italy) is a self-expanding bovine pericardial prosthesis placed in a nitinol stent designed to facilitate aortic valve implantation. A systematic review and meta-analysis demonstrated that the early clinical and hemodynamic characteristics of the Perceval valve are satisfactory and comparable to those of conventional AVRs. This literature review was carried out in accordance with the PRISM statement. The databases searched in this review included Pubmed, Web of Science, Scopus and Cochrane databases for systematic reviews


2007 ◽  
Vol 83 (6) ◽  
pp. 2050-2053 ◽  
Author(s):  
Tohru Takaseya ◽  
Takemi Kawara ◽  
Shigehiko Tokunaga ◽  
Michitaka Kohno ◽  
Yasuhisa Oishi ◽  
...  

2020 ◽  
Vol 87 (9-10) ◽  
pp. 40-43
Author(s):  
V. V. Popov ◽  
R. M. Vitovskyi ◽  
Yu. V. Bakhovska ◽  
O. O. Bolshak ◽  
K. Ye. Vakulenko ◽  
...  

Objective. To research of possibilities of reconstruction of aorta`s ostium and ascending aorta during aortic valve replacement and simultaneous correction of mitral valve defects at patients with narrow aorta`s ostium. Materials and methods. The study group consisted of 46 patients with mitral-aortic heart diseases and combination with a narrow aortic mouth, who were operated on at the A Amosov National Institute of Cardiovascular surgery for the period from January 1, 2006 to January 1, 2020. All patients underwent reconstruction of the aortic root and ascending aorta according to the original method of posterior aortoplasty. There were 26 men (56.5%) and 20 women (43.5%). The age of patients ranged from 23 to 72 years (average - 58.4±7.3 years). 8 (17.4%) patients belonged to class III NYHA, 38 (82.6%) - to class IV. Results. Of the 46 operated patients at the hospital stage (30 days after surgery), 4 died (hospital mortality 8.7%). No fatalities were associated with surgical technique. The dynamics of echocardiographic parameters at the hospital stage was as follows: the systolic gradient on the aortic valve was before surgery 112.1 ± 15.2 mm Hg, on the aortic prosthesis at discharge - 23.2 ± 6.4 mm Hg; end-systolic index (ESI) of the left ventricle (ml/m²) - 59.1 ± 7.6 (before surgery) and 48.3 ± 5.9 (after surgery); left ventricle ejection fraction (EF) - 0.45 ± 0.04 (before surgery) and 0.53 ± 0.04 (after surgery). Conclusions. The proposed original technique of posterior aortoplasty allows to effectively expand the mouth of the aorta for further implantation of an artificial heart valve of larger diameter. The technique is quite safe. At the hospital stage there are no complications directly related to the technique of operations. At the early postoperative period, the morphometric parameters of the left ventricle (EF and ESI) improved. The technique can be successfully used for the correction of combined mitral-aortic valve defects.


2019 ◽  
Vol 3 (02) ◽  
pp. 099-100
Author(s):  
Ujjwal Kumar Chowdhury ◽  
Niwin George ◽  
Sukhjeet Singh ◽  
Poonam Malhotra Kapoor ◽  
Lakshmi Kumari Sankhyan ◽  
...  

AbstractWe performed Dacron patch closure of ventricular septal defect with concomitant aortic valve replacement using a St. Jude Medical mechanical aortic prosthesis for a patient with ventricular septal defect and severely deformed and irreparable aortic valve. We highlight the technical details of the procedure to prevent paravalvular aortic leakage and residual ventricular septal defect.


2002 ◽  
Vol 26 (8) ◽  
pp. 706-710 ◽  
Author(s):  
Yoshito Kawachi ◽  
Kouich Arinaga ◽  
Atsuhiro Nakashima ◽  
Yoshihiro Toshima ◽  
Hiroshi Kawano ◽  
...  

1997 ◽  
Vol 12 (6) ◽  
pp. 363-370 ◽  
Author(s):  
S. Fehmi Katircioglu ◽  
Birol Yamak ◽  
A. Tulga Ulus ◽  
H. Zafer Iscan ◽  
Binali Mavitas ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document